- BKNGBooking$132BReported
BKNGQ3 2015
Booking
View full reportEPS
Estimated
$24.23
Actual
$25.354.6%
Revenue
Estimated
$3.0B
Actual
$3.1B4.6%
- AUAngloGold Ashanti$48.6BReported
AUQ3 2015
AngloGold Ashanti
View full reportEPS
Estimated
$0.05
Actual
-$0.18460.0%
Revenue
Estimated
—
Actual
$857.3M
- ALNYAlnylam$40.7BReported
ALNYQ3 2015
Alnylam
View full reportEPS
Estimated
-$0.94
Actual
-$0.913.2%
Revenue
Estimated
$6.3M
Actual
$6.3M0.1%
- BAPCredicorp$27.2BReported
BAPQ3 2015
Credicorp
View full reportEPS
Estimated
$2.84
Actual
$3.1510.9%
Revenue
Estimated
$3.4B
Actual
$2.9B13.5%
- STRLSterling$25.9BReported
STRLQ3 2015
Sterling
View full reportEPS
Estimated
-$0.06
Actual
$0.09250.0%
Revenue
Estimated
$880.0M
Actual
$176.0M80.0%
- RPRXRoyalty Pharma$24.1BReported
RPRXQ3 2015
Royalty Pharma
View full reportEPS
Estimated
-$0.29
Actual
-$0.276.9%
Revenue
Estimated
—
Actual
$1.0K
- WWDWoodward$21.1BReported
WWDQ4 2015
Woodward
View full reportEPS
Estimated
$0.75
Actual
$0.772.7%
Revenue
Estimated
$548.0M
Actual
$562.6M2.7%
- IFFIFF$19.9BReported
IFFQ3 2015
IFF
View full reportEPS
Estimated
$1.35
Actual
$1.393.0%
Revenue
Estimated
$743.1M
Actual
$765.1M3.0%
- RBCRBC Bearings$18.3BReported
RBCQ3 2015
RBC Bearings
View full reportEPS
Estimated
—
Actual
$1.43
Revenue
Estimated
—
Actual
$106.3M
- SNSharkNinja$16.9BReported
SNQ3 2015
SharkNinja
View full reportEPS
Estimated
-$0.60
Actual
-$0.4918.3%
Revenue
Estimated
$143.9M
Actual
$114.5M20.4%
- JAZZJazz Pharmaceuticals$14.8BReported
JAZZQ3 2015
Jazz Pharmaceuticals
View full reportEPS
Estimated
$2.55
Actual
$2.521.2%
Revenue
Estimated
$346.3M
Actual
$340.9M1.6%
- IONSIonis$12.8BReported
IONSQ3 2015
Ionis
View full reportEPS
Estimated
-$0.31
Actual
-$0.1745.2%
Revenue
Estimated
$50.8M
Actual
$49.1M3.2%
- VSATViasat$11.8BReported
VSATQ2 2016
Viasat
View full reportEPS
Estimated
$0.32
Actual
$0.306.3%
Revenue
Estimated
$412.2M
Actual
$353.3M14.3%
- MTCHMatch Group$8.5BReported
MTCHQ3 2015
Match Group
View full reportEPS
Estimated
$0.00
Actual
$0.79
Revenue
Estimated
$0.00
Actual
$838.6M
- ROKRockwell Automation$50.6BReported
ROKQ4 2015
Rockwell Automation
View full reportEPS
Estimated
$1.79
Actual
$1.5712.3%
Revenue
Estimated
$1.8B
Actual
$1.6B12.3%
- DHID.R. Horton$41.7BReported
DHIQ4 2015
D.R. Horton
View full reportEPS
Estimated
$0.62
Actual
$0.611.6%
Revenue
Estimated
$3.2B
Actual
$3.2B1.6%
- KGCKinross Gold$35.0BReported
KGCQ3 2015
Kinross Gold
View full reportEPS
Estimated
-$0.03
Actual
-$0.0233.3%
Revenue
Estimated
$719.1M
Actual
$809.4M12.6%
- ARESAres$28.4BReported
ARESQ3 2015
Ares
View full reportEPS
Estimated
$0.17
Actual
-$0.14183.9%
Revenue
Estimated
$365.6M
Actual
$143.9M60.6%
- AERAerCap$23.2BReported
AERQ3 2015
AerCap
View full reportEPS
Estimated
$1.48
Actual
$1.6511.5%
Revenue
Estimated
$1.3B
Actual
$1.2B3.4%
- HTHTHuazhu$13.7BReported
HTHTQ3 2015
Huazhu
View full reportEPS
Estimated
$0.12
Actual
$0.1525.0%
Revenue
Estimated
$1.4B
Actual
$251.8M81.8%
- EXELExelixis$12.9BReported
EXELQ3 2015
Exelixis
View full reportEPS
Estimated
-$0.20
Actual
-$0.2210.0%
Revenue
Estimated
$9.0M
Actual
$9.9M10.0%
- BF-ABrown-Forman$12.3BReported
BF-AQ2 2016
Brown-Forman
View full reportEPS
Estimated
$0.00
Actual
$0.39
Revenue
Estimated
$0.00
Actual
$1.1B
- ZBRAZebra$11.8BReported
ZBRAQ3 2015
Zebra
View full reportEPS
Estimated
$1.22
Actual
$1.3913.9%
Revenue
Estimated
$810.8M
Actual
$916.3M13.0%
- RIOTRiot$10.5BReported
RIOTQ3 2015
Riot
View full reportEPS
Estimated
$0.00
Actual
-$0.41
Revenue
Estimated
$0.00
Actual
$81.3K
- ESIElement Solutions$10.2BReported
ESIQ3 2015
Element Solutions
View full reportEPS
Estimated
$0.11
Actual
$0.0645.5%
Revenue
Estimated
$995.5M
Actual
$597.3M40.0%
- WWayfair$9.6BReported
WQ3 2015
Wayfair
View full reportEPS
Estimated
-$0.24
Actual
-$0.1345.8%
Revenue
Estimated
$1.1B
Actual
$594.0M45.8%
- ACMAECOM$9.1BReported
ACMQ4 2015
AECOM
View full reportEPS
Estimated
$0.93
Actual
$0.952.2%
Revenue
Estimated
$4.9B
Actual
$4.7B4.2%
- MIDDMiddleby$7.0BReported
MIDDQ3 2015
Middleby
View full reportEPS
Estimated
$1.06
Actual
$1.041.9%
Revenue
Estimated
$457.6M
Actual
$449.0M1.9%
- NTESNetEase$79.2BReported
NTESQ3 2015
NetEase
View full reportEPS
Estimated
$0.36
Actual
$0.4936.1%
Revenue
Estimated
$5.3B
Actual
$1.1B80.1%
- FNVFNV$43.5BReported
FNVQ3 2015
FNV
View full reportEPS
Estimated
$0.13
Actual
$0.127.7%
Revenue
Estimated
$104.4M
Actual
$103.7M0.6%
- TSEMTower$30.8BReported
TSEMQ3 2015
Tower
View full reportEPS
Estimated
$0.59
Actual
$0.625.1%
Revenue
Estimated
$224.5M
Actual
$244.2M8.8%
- GIBCGI$14.2BReported
GIBQ4 2015
CGI
View full reportEPS
Estimated
$0.80
Actual
$0.822.5%
Revenue
Estimated
$2.5B
Actual
$2.6B1.8%
- TTEKTetra Tech$7.2BReported
TTEKQ4 2015
Tetra Tech
View full reportEPS
Estimated
$0.10
Actual
$0.100.0%
Revenue
Estimated
$427.0M
Actual
$427.0M0.0%
- MMacy's$5.9BReported
MQ3 2015
Macy's
View full reportEPS
Estimated
$0.50
Actual
$0.5612.0%
Revenue
Estimated
$5.1B
Actual
$5.9B15.7%
- ADTADT$5.4BReported
ADTQ4 2015
ADT
View full reportEPS
Estimated
$0.48
Actual
$0.516.3%
Revenue
Estimated
$906.2M
Actual
$899.0M0.8%
- TGBTaseko Mines$2.6BReported
TGBQ3 2015
Taseko Mines
View full reportEPS
Estimated
-$0.01
Actual
-$0.010.0%
Revenue
Estimated
$89.5M
Actual
$67.1M25.0%
- FRPTFreshpet$2.6BReported
FRPTQ3 2015
Freshpet
View full reportEPS
Estimated
-$0.03
Actual
-$0.0571.8%
Revenue
Estimated
$25.2M
Actual
$30.6M21.2%
- FLOFlowers Foods$1.6BReported
FLOQ3 2015
Flowers Foods
View full reportEPS
Estimated
$0.23
Actual
$0.230.0%
Revenue
Estimated
$885.3M
Actual
$885.3M0.0%
- CDNACareDx$1.2BReported
CDNAQ3 2015
CareDx
View full reportEPS
Estimated
-$0.25
Actual
-$0.2916.0%
Revenue
Estimated
$5.6M
Actual
$7.2M28.0%
- NATNordic American Tankers$1.1BReported
NATQ3 2015
Nordic American Tankers
View full reportEPS
Estimated
$0.27
Actual
$0.297.4%
Revenue
Estimated
$94.9M
Actual
$66.7M29.7%
- SPTNSpartanNash$907MReported
SPTNQ3 2015
SpartanNash
View full reportEPS
Estimated
$0.42
Actual
$0.4916.7%
Revenue
Estimated
$1.7B
Actual
$1.8B7.4%
- CSCOCisco$468BReported
CSCOQ1 2016
Cisco
View full reportEPS
Estimated
$0.56
Actual
$0.595.4%
Revenue
Estimated
$12.0B
Actual
$12.7B5.4%
- AMATApplied Materials$357BReported
AMATQ4 2015
Applied Materials
View full reportEPS
Estimated
$0.29
Actual
$0.290.0%
Revenue
Estimated
$2.4B
Actual
$2.4B0.0%
- SBSSABESP$97.8BReported
SBSQ3 2015
SABESP
View full reportEPS
Estimated
-$0.06
Actual
-$0.23277.0%
Revenue
Estimated
$4.9B
Actual
$628.3M87.1%
- TDGTransdigm$70.8BReported
TDGQ4 2015
Transdigm
View full reportEPS
Estimated
$2.56
Actual
$2.8310.5%
Revenue
Estimated
$732.5M
Actual
$809.8M10.5%
- PBRPetrobras$70.1BReported
PBRQ3 2015
Petrobras
View full reportEPS
Estimated
$0.05
Actual
$0.0420.0%
Revenue
Estimated
$27.1B
Actual
$23.2B14.5%
- MFCManulife$64.2BReported
MFCQ3 2015
Manulife
View full reportEPS
Estimated
$0.35
Actual
$0.328.6%
Revenue
Estimated
$5.2B
Actual
$5.3B2.7%
- ABEVAmbev$49.9BReported
ABEVQ3 2015
Ambev
View full reportEPS
Estimated
$0.06
Actual
$0.0516.7%
Revenue
Estimated
$12.5B
Actual
$10.7B14.3%
- NTRANatera$30.6BReported
NTRAQ3 2015
Natera
View full reportEPS
Estimated
-$0.42
Actual
-$0.397.1%
Revenue
Estimated
$53.0M
Actual
$44.9M15.2%
- PAASPan American Silver$23.3BReported
PAASQ3 2015
Pan American Silver
View full reportEPS
Estimated
-$0.12
Actual
-$0.0650.0%
Revenue
Estimated
$164.2M
Actual
$159.4M2.9%
- AGIAlamos Gold$16.6BReported
AGIQ3 2015
Alamos Gold
View full reportEPS
Estimated
-$0.05
Actual
-$0.13160.0%
Revenue
Estimated
$111.3M
Actual
$103.6M6.9%
- OVVOvintiv$15.7BReported
OVVQ3 2015
Ovintiv
View full reportEPS
Estimated
-$0.18
Actual
-$0.1516.7%
Revenue
Estimated
$1.6B
Actual
$1.3B20.0%
- ASNDAscendis Pharma$14.7BReported
ASNDQ3 2015
Ascendis Pharma
View full reportEPS
Estimated
-$0.65
Actual
-$0.3250.4%
Revenue
Estimated
$3.0M
Actual
$2.3M25.4%
- RRXRegal Rexnord$13.5BReported
RRXQ3 2015
Regal Rexnord
View full reportEPS
Estimated
$1.42
Actual
$1.430.7%
Revenue
Estimated
$0.00
Actual
$882.3M
- PENPenumbra$12.5BReported
PENQ3 2015
Penumbra
View full reportEPS
Estimated
-$0.18
Actual
$0.03116.7%
Revenue
Estimated
$99.8M
Actual
$50.4M49.5%
- NTRANatera$30.6BReported
NTRAQ3 2014
Natera
View full reportEPS
Estimated
$0.00
Actual
-$1.35
Revenue
Estimated
$0.00
Actual
$46.3M
- HLIHoulihan Lokey$10.2BReported
HLIQ4 2015
Houlihan Lokey
View full reportEPS
Estimated
$0.00
Actual
$0.43
Revenue
Estimated
$0.00
Actual
$186.5M
- HLIHoulihan Lokey$10.2BReported
HLIQ2 2015
Houlihan Lokey
View full reportEPS
Estimated
$0.00
Actual
$0.29
Revenue
Estimated
$0.00
Actual
$156.3M
- HLIHoulihan Lokey$10.2BReported
HLIQ1 2015
Houlihan Lokey
View full reportEPS
Estimated
$0.00
Actual
$0.25
Revenue
Estimated
$0.00
Actual
$141.5M
- UNITUniti$2.8BReported
UNITQ3 2015
Uniti
View full reportEPS
Estimated
$0.07
Actual
$0.1157.1%
Revenue
Estimated
$202.5M
Actual
$302.4M49.3%
- AUPHAurinia$2.0BReported
AUPHQ4 2015
Aurinia
View full reportEPS
Estimated
-$0.23
Actual
-$0.1821.7%
Revenue
Estimated
$82.5K
Actual
$57.0K30.9%
- VRDNViridian Therapeutics$1.9BReported
VRDNQ3 2015
Viridian Therapeutics
View full reportEPS
Estimated
-$83.25
Actual
-$87.755.4%
Revenue
Estimated
$0.00
Actual
$1.3M
- SGRYSurgery Partners$1.8BReported
SGRYQ4 2014
Surgery Partners
View full reportEPS
Estimated
$0.00
Actual
-$1.67
Revenue
Estimated
$0.00
Actual
$179.7M
- SGRYSurgery Partners$1.8BReported
SGRYQ3 2014
Surgery Partners
View full reportEPS
Estimated
$0.00
Actual
-$0.37
Revenue
Estimated
$0.00
Actual
$223.6M
- VCELVericel$1.7BReported
VCELQ3 2015
Vericel
View full reportEPS
Estimated
-$0.21
Actual
-$0.2623.8%
Revenue
Estimated
$10.4M
Actual
$11.3M8.3%
- LOBLive Oak$1.7BReported
LOBQ3 2014
Live Oak
View full reportEPS
Estimated
$0.00
Actual
$0.01
Revenue
Estimated
$0.00
Actual
$20.6M
- PVLAPalvella Therapeutics Inc$1.7BReported
PVLAQ3 2015
Palvella Therapeutics Inc
View full reportEPS
Estimated
—
Actual
—
Revenue
Estimated
—
Actual
$414.6K
- ATLCAtlanticus$1.3BReported
ATLCQ3 2015
Atlanticus
View full reportEPS
Estimated
$0.00
Actual
$0.03
Revenue
Estimated
$0.00
Actual
$18.2M
- GNKGenco$1.0BReported
GNKQ3 2015
Genco
View full reportEPS
Estimated
-$3.40
Actual
-$9.50179.4%
Revenue
Estimated
$35.1M
Actual
$50.0M42.4%
- VANIVivani Medical, Inc$111MReported
VANIQ3 2015
Vivani Medical, Inc
View full reportEPS
Estimated
—
Actual
—
Revenue
Estimated
—
Actual
$2.2M